Atlantic Equities analyst Steve Chesney maintains Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $220 to $295.
‘OpenAI’s Sam Altman Seeks To Raise Billions For Network Of AI Chip Factories’ – BNN Bloomberg
https://www.bnnbloomberg.ca/altman-sought-billions-for-ai-chip-venture-before-openai-ouster-1.2000797#:~:text=Altman%20Sought%20Billions%20For%20AI%20Chip%20Venture%20Before%20OpenAI%20Ouster,-Ed%20Ludlow%20and&text=
